ArticleOncotarget2016

Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.

Young-Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.